Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
Clinical trial NCT06478212 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06478212
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-22
- Primary completion
- 2027-11-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.